Datar Cancer Genetics testing available in AUSTRALIA
We understand that every cancer and every patient is unique, which is why tailored treatments are essential for success. Our solutions offer in-depth genomic and cellular analysis to identify personalised treatment strategies. By recognising the distinctiveness of each cancer and patient, treatment success rates can be enhanced. Join us in advancing cancer care with personalised solutions that prioritise individual needs and treatment effectiveness.
OUR MISSION
Datar Cancer Genetics testing, available through Cancer Profiling Australia, specialises in tailored solutions for advanced-stage or difficult-to-treat solid tumours, such as breast and prostate cancer. We also prioritise the crucial aspect of early cancer detection, particularly where timely intervention significantly improves treatment outcomes. Leveraging insights from blood analysis and advanced AI, we optimise therapy strategies to enhance patient care. Through extensive clinical studies spanning several years, we have developed evidence-based testing protocols for both therapy management and cancer screening. With over 40,000 patients enrolled in our studies to date, we continue to make significant advancements in cancer diagnostics and treatment methodologies.
Services
The most comprehensive tumour investigation.
100,000,000
data points are analysed
Deep genomic analysis of solid tumours.
NEWS & EVENTS
-
ESMO 2023 – DR. CROOK PRESENTS TOGETHER WITH DATAR CANCER GENETICS
We are delighted to announce that Dr Timothy Crook, Consultant Medical Oncologist at Cromwell Hospital, is presenting alongside international colleagues at the European Society for Medical Oncology (ESMO) in October, 2023.
-
FURTHER BREAKTHROUGH DEVICE DESIGNATION FROM THE FDA
A prospective, blind study was conducted at Imperial College London to provide clinical evidence. In two case-controlled studies, a 98% sensitivity and specificity in the detection of malignant brain tumours and in the differentiation between malignant and benign CNS diseases was established.
ABOUT US
Datar Cancer Genetics are a prominent molecular oncology institution boasting a global team of over 250 professionals. With laboratories situated in the UK and India, complemented by an in-house bioinformatics team and an extensive database, they ensure reporting aligned with the latest scientific benchmarks.
Accredited by NABL, ISO 15189, CAP, and CLIA, their laboratories uphold the highest standards. Collaborating with research institutes, hospitals, and physicians across the globe—including the USA, UK, India, and the EU— they are dedicated to advancing oncological research and patient care worldwide.
CONTACT
Cancer Profiling Australia
903/50 Clarence Street,
SYDNEY NSW 2000
PH +61 1300 282 482
FAX +61 2 8088 7097
Email: info@cancerprofiling.com.au